Application 204042
- Type
- NDA
- Sponsor
- JANSSEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | INVOKANA | CANAGLIFLOZIN | TABLET;ORAL | 100MG | Yes | No |
| 002 | INVOKANA | CANAGLIFLOZIN | TABLET;ORAL | 300MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N204042-001 | INVOKANA | CANAGLIFLOZIN | 100MG | TABLET / ORAL | AB | RLD | 2013-03-29 |
| N204042-002 | INVOKANA | CANAGLIFLOZIN | 300MG | TABLET / ORAL | AB | RLD, RS | 2013-03-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N204042-001 | AB |
| N204042-002 | AB |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N204042-001 | 7943788 | 2027-07-14 | Drug substance, Drug product | 2013-04-16 | |
| N204042-001 | 8513202 | 2027-12-03 | U-2441 | Drug substance, Drug product | 2013-04-16 |
| N204042-001 | 8513202 | 2027-12-03 | U-2632 | Drug substance, Drug product | 2013-04-16 |
| N204042-001 | 8513202 | 2027-12-03 | U-493 | Drug substance, Drug product | 2013-04-16 |
| N204042-001 | 7943788*PED | 2028-01-14 | Pediatric extension | ||
| N204042-001 | 8513202*PED | 2028-06-03 | Pediatric extension | ||
| N204042-001 | 7943582 | 2029-02-26 | U-2441 | Drug substance, Drug product | 2013-04-16 |
| N204042-001 | 7943582 | 2029-02-26 | U-2632 | Drug substance, Drug product | 2013-04-16 |
| N204042-001 | 7943582 | 2029-02-26 | U-493 | Drug substance, Drug product | 2013-04-16 |
| N204042-001 | 7943582*PED | 2029-08-26 | Pediatric extension | ||
| N204042-002 | 7943788 | 2027-07-14 | Drug substance, Drug product | ||
| N204042-002 | 8513202 | 2027-12-03 | U-2441 | Drug substance, Drug product | 2013-04-16 |
| N204042-002 | 8513202 | 2027-12-03 | U-2632 | Drug substance, Drug product | 2013-04-16 |
| N204042-002 | 8513202 | 2027-12-03 | U-493 | Drug substance, Drug product | 2013-04-16 |
| N204042-002 | 7943788*PED | 2028-01-14 | Pediatric extension | ||
| N204042-002 | 8513202*PED | 2028-06-03 | Pediatric extension | ||
| N204042-002 | 7943582 | 2029-02-26 | U-2441 | Drug substance, Drug product | 2013-04-16 |
| N204042-002 | 7943582 | 2029-02-26 | U-2632 | Drug substance, Drug product | 2013-04-16 |
| N204042-002 | 7943582 | 2029-02-26 | U-493 | Drug substance, Drug product | 2013-04-16 |
| N204042-002 | 7943582*PED | 2029-08-26 | Pediatric extension |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N204042-001 | NPP | 2027-12-18 |
| N204042-001 | PED | 2028-06-18 |
| N204042-002 | NPP | 2027-12-18 |
| N204042-002 | PED | 2028-06-18 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N204042-001 | INVOKANA | 100MG | TABLET / ORAL | RLD | 2013-03-29 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N204042-002 | INVOKANA | 300MG | TABLET / ORAL | RLD, RS | 2013-03-29 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N204042-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N204042-002 | AB | 1 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N204042-001 | 7943788 | 2027-07-14 | Drug substance, Drug product | 2013-04-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-001 | 8513202 | 2027-12-03 | U-493 | Drug substance, Drug product | 2013-04-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-001 | 8513202 | 2027-12-03 | U-2441 | Drug substance, Drug product | 2013-04-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-001 | 8513202 | 2027-12-03 | U-2632 | Drug substance, Drug product | 2013-04-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-001 | 7943788*PED | 2028-01-14 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N204042-001 | 8513202*PED | 2028-06-03 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N204042-001 | 7943582 | 2029-02-26 | U-2441 | Drug substance, Drug product | 2013-04-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-001 | 7943582 | 2029-02-26 | U-2632 | Drug substance, Drug product | 2013-04-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-001 | 7943582 | 2029-02-26 | U-493 | Drug substance, Drug product | 2013-04-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-001 | 7943582*PED | 2029-08-26 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N204042-002 | 7943788 | 2027-07-14 | Drug substance, Drug product | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N204042-002 | 8513202 | 2027-12-03 | U-493 | Drug substance, Drug product | 2013-04-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-002 | 8513202 | 2027-12-03 | U-2632 | Drug substance, Drug product | 2013-04-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-002 | 8513202 | 2027-12-03 | U-2441 | Drug substance, Drug product | 2013-04-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-002 | 7943788*PED | 2028-01-14 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N204042-002 | 8513202*PED | 2028-06-03 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N204042-002 | 7943582 | 2029-02-26 | U-493 | Drug substance, Drug product | 2013-04-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-002 | 7943582 | 2029-02-26 | U-2632 | Drug substance, Drug product | 2013-04-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-002 | 7943582 | 2029-02-26 | U-2441 | Drug substance, Drug product | 2013-04-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-002 | 7943582*PED | 2029-08-26 | Pediatric extension | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | 8222219 | 2025-04-11 | U-493 | 2013-04-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | 8222219 | 2025-04-11 | U-2441 | 2013-04-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | 8222219 | 2025-04-11 | U-2632 | 2013-04-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | 8222219*PED | 2025-10-11 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | 7943788 | 2027-07-14 | Drug substance, Drug product | 2013-04-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | 8513202 | 2027-12-03 | U-493 | Drug substance, Drug product | 2013-04-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | 8513202 | 2027-12-03 | U-2441 | Drug substance, Drug product | 2013-04-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | 8513202 | 2027-12-03 | U-2632 | Drug substance, Drug product | 2013-04-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | 7943788*PED | 2028-01-14 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | 8513202*PED | 2028-06-03 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | 7943582 | 2029-02-26 | U-2441 | Drug substance, Drug product | 2013-04-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | 7943582 | 2029-02-26 | U-2632 | Drug substance, Drug product | 2013-04-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | 7943582 | 2029-02-26 | U-493 | Drug substance, Drug product | 2013-04-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | 7943582*PED | 2029-08-26 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-002 | 8222219 | 2025-04-11 | U-493 | 2013-04-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-002 | 8222219 | 2025-04-11 | U-2632 | 2013-04-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-002 | 8222219 | 2025-04-11 | U-2441 | 2013-04-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-002 | 8222219*PED | 2025-10-11 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-002 | 7943788 | 2027-07-14 | Drug substance, Drug product | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-002 | 8513202 | 2027-12-03 | U-493 | Drug substance, Drug product | 2013-04-16 | 31067a03dcf5… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N204042-001 | NPP | 2027-12-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-001 | PED | 2028-06-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-002 | NPP | 2027-12-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204042-002 | PED | 2028-06-18 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | NPP | 2027-12-18 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-001 | PED | 2028-06-18 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-002 | NPP | 2027-12-18 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204042-002 | PED | 2028-06-18 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N204042-001 | NPP | 2027-12-18 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204042-001 | PED | 2028-06-18 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204042-002 | NPP | 2027-12-18 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204042-002 | PED | 2028-06-18 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204042-001 | NPP | 2027-12-18 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204042-001 | PED | 2028-06-18 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204042-002 | NPP | 2027-12-18 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204042-002 | PED | 2028-06-18 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204042-001 | NPP | 2027-12-18 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204042-001 | PED | 2028-06-18 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204042-002 | NPP | 2027-12-18 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204042-002 | PED | 2028-06-18 | b8a1b40f171c… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N204042-001 | I-809 | 2022-09-27 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N204042-002 | I-809 | 2022-09-27 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N204042-001 | I-809 | 2022-09-27 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N204042-002 | I-809 | 2022-09-27 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N204042-001 | I-809 | 2022-09-27 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N204042-002 | I-809 | 2022-09-27 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N204042-001 | I-733 | 2019-05-20 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N204042-001 | M-197 | 2020-02-01 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N204042-001 | I-788 | 2021-10-29 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N204042-001 | I-809 | 2022-09-27 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N204042-002 | I-733 | 2019-05-20 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N204042-002 | M-197 | 2020-02-01 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N204042-002 | I-788 | 2021-10-29 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N204042-002 | I-809 | 2022-09-27 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N204042-001 | I-809 | 2022-09-27 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N204042-002 | I-809 | 2022-09-27 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N204042-001 | I-788 | 2021-10-29 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N204042-001 | I-809 | 2022-09-27 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N204042-002 | I-788 | 2021-10-29 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N204042-002 | I-809 | 2022-09-27 | 782e0a99824c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| INVOKANA | CANAGLIFLOZIN | Janssen Pharmaceuticals, Inc. | b9057d3b-b104-4f09-8a61-c61ef9d4a3f3 | 2026-06-11 | Warnings, Adverse reactions | 204042 NDA204042 50458-140 50458-141 |
| INVOKANA | CANAGLIFLOZIN | Cardinal Health 107, LLC | 5f76e16f-0c24-454a-81af-4080b312c940 | 2026-02-17 | Warnings, Adverse reactions | 204042 NDA204042 55154-1425 55154-1426 |
| INVOKANA | CANAGLIFLOZIN | A-S Medication Solutions | 9679460c-55f7-4826-b55c-fe116f020358 | 2023-12-15 | Warnings, Adverse reactions | 204042 NDA204042 50090-4364 |
| INVOKANA | CANAGLIFLOZIN | A-S Medication Solutions | 8d5f892b-e4f3-4a9e-9a91-95e2fca34144 | 2023-12-15 | Warnings, Adverse reactions | 204042 NDA204042 50090-5034 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50090-4364 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-4364 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-4364 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-4364 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5029 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5029 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5033 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5033 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5033 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5034 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5034 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5034 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50090-5034 | INVOKANA | canagliflozin | A-S Medication Solutions | NDA | Current |
| 50458-140 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-140 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-140 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-140 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-140 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-140 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-140 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-141 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-141 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-141 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-141 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-141 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-141 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-141 | INVOKANA | canagliflozin | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 55154-1425 | INVOKANA | canagliflozin | Cardinal Health | NDA | Current |
| 55154-1425 | INVOKANA | canagliflozin | Cardinal Health | NDA | Current |
| 55154-1425 | INVOKANA | canagliflozin | Cardinal Health 107, LLC | NDA | Current |
| 55154-1425 | INVOKANA | canagliflozin | .Cardinal Health | NDA | Current |
| 55154-1425 | INVOKANA | canagliflozin | .Cardinal Health | NDA | Current |
| 55154-1425 | INVOKANA | canagliflozin | Cardinal Health | NDA | Current |
| 55154-1425 | INVOKANA | canagliflozin | Cardinal Health | NDA | Current |
| 55154-1426 | INVOKANA | canagliflozin | Cardinal Health | NDA | Current |
| 55154-1426 | INVOKANA | canagliflozin | Cardinal Health | NDA | Current |
| 55154-1426 | INVOKANA | canagliflozin | Cardinal Health 107, LLC | NDA | Current |
| 55154-1426 | INVOKANA | canagliflozin | .Cardinal Health | NDA | Current |
| 55154-1426 | INVOKANA | canagliflozin | .Cardinal Health | NDA | Current |
| 55154-1426 | INVOKANA | canagliflozin | Cardinal Health | NDA | Current |
| 55154-1426 | INVOKANA | canagliflozin | Cardinal Health | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 80653 | SUPPL | 2024-12-19 |
| 80631 | SUPPL | 2024-12-19 |
| 80630 | SUPPL | 2024-12-19 |
| 79481 | SUPPL | 2024-08-26 |
| 79480 | SUPPL | 2024-08-26 |
| 79470 | SUPPL | 2024-08-26 |
| 79469 | SUPPL | 2024-08-26 |
| 74709 | SUPPL | 2023-07-07 |
| 74697 | SUPPL | 2023-07-06 |
| 72362 | SUPPL | 2022-10-17 |
| 72361 | SUPPL | 2022-10-17 |
| 72331 | SUPPL | 2022-10-14 |
| 68764 | SUPPL | 2021-09-24 |
| 64316 | SUPPL | 2020-08-19 |
| 64315 | SUPPL | 2020-08-19 |
| 64302 | SUPPL | 2020-08-19 |
| 62296 | SUPPL | 2020-03-24 |
| 61692 | SUPPL | 2020-01-27 |
| 61654 | SUPPL | 2020-01-27 |
| 61648 | SUPPL | 2020-01-27 |
| 60529 | SUPPL | 2019-10-10 |
| 60518 | SUPPL | 2019-10-10 |
| 60165 | SUPPL | 2019-09-30 |
| 60160 | SUPPL | 2019-09-30 |
| 56213 | SUPPL | 2018-10-31 |
| 56204 | SUPPL | 2018-10-31 |
| 56192 | SUPPL | 2018-10-30 |
| 56172 | SUPPL | 2018-10-30 |
| 52736 | SUPPL | 2018-02-27 |
| 49116 | SUPPL | 2017-07-28 |
| 49064 | SUPPL | 2017-07-25 |
| 47085 | SUPPL | 2017-02-01 |
| 47084 | SUPPL | 2017-02-01 |
| 45094 | SUPPL | 2016-08-22 |
| 45142 | SUPPL | 2016-08-17 |
| 32496 | SUPPL | 2016-05-24 |
| 10288 | SUPPL | 2016-05-24 |
| 40349 | SUPPL | 2016-05-23 |
| 19518 | SUPPL | 2016-05-23 |
| 40348 | SUPPL | 2016-03-30 |
| 32494 | SUPPL | 2016-03-30 |
| 32495 | SUPPL | 2015-12-08 |
| 19517 | SUPPL | 2015-12-08 |
| 19516 | SUPPL | 2015-09-11 |
| 40347 | SUPPL | 2015-03-05 |
| 10287 | SUPPL | 2015-03-04 |
| 10286 | SUPPL | 2014-05-20 |
| 40346 | SUPPL | 2014-05-19 |
| 43454 | ORIG | 2013-05-10 |
| 60772 | ORIG | 2013-04-01 |
| 40345 | ORIG | 2013-04-01 |
| 32493 | ORIG | 2013-04-01 |